4.7 Article

Simulation of crosstalk between small GTPase RhoA and EGFR-ERK signaling pathway via MEKK1

Journal

BIOINFORMATICS
Volume 25, Issue 3, Pages 358-364

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bioinformatics/btn635

Keywords

-

Funding

  1. National University of Singapore Academic Research Fund [R-148-000-081-112/101]
  2. Ministry of Science and Technology of China [2004CB720103, 2003CB715901, 2006AA02Z317]
  3. National Natural Science Foundation of China [30500107]
  4. Shanghai Municipal Education Commission [2000236018, 2000236016]
  5. Science and Technology Commission of Shanghai Municipality of China [06PJ14072]

Ask authors/readers for more resources

Motivation: Small GTPase RhoA regulates cell-cycle progression via several mechanisms. Apart from its actions via ROCK, RhoA has recently been found to activate a scaffold protein MEKK1 known to promote ERK activation. We examined whether RhoA can substantially affect ERK activity via this MEKK1-mediated crosstalk between RhoA and EGFR-ERK pathway. By extending the published EGFR-ERK simulation models represented by ordinary differential equations, we developed a simulation model that includes this crosstalk, which was validated with a number of experimental findings and published simulation results. Results: Our simulation suggested that, via this crosstalk, RhoA elevation substantially prolonged duration of ERK activation at both normal and reduced Ras levels. Our model suggests ERK may be activated in the absence of Ras. When Ras is overexpressed, RhoA elevation significantly prolongs duration of ERK activation but reduces the amount of active ERK partly due to competitive binding between ERK and RhoA to MEKK1. Our results indicated possible roles of RhoA in affecting ERK activities via MEKK1-mediated crosstalk, which seems to be supported by indications from several experimental studies that may also implicate the collective regulation of cell fate and progression of cancer and other diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available